CBU
REGN icon

CIBC Bank USA’s Regeneron Pharmaceuticals REGN Stock Holding History

CIBC Bank USA’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$556K Buy
1,480
+50
+3% +$16.8K 0.07% 160
2019
Q3 		$397K Hold
1,430
– – 0.06% 193
2019
Q2 		$448K Buy
+1,430
New +$476K 0.06% 167
2016
Q1 		– Sell
-1,496
Closed -$812K – 255
2015
Q4 		$812K Buy
1,496
+1
+0.1% +$542 0.14% 97
2015
Q3 		$696K Sell
1,495
-120
-7% -$64.4K 0.13% 111
2015
Q2 		$824K Sell
1,615
-45
-3% -$22K 0.14% 105
2015
Q1 		$750K Sell
1,660
-70
-4% -$29.7K 0.13% 111
2014
Q4 		$710K Sell
1,730
-80
-4% -$31.5K 0.12% 133
2014
Q3 		$653K Buy
1,810
+75
+4% +$25.1K 0.13% 136
2014
Q2 		$490K Buy
1,735
+580
+50% +$172K 0.09% 178
2014
Q1 		$347K Sell
1,155
-320
-22% -$98.6K 0.07% 223
2013
Q4 		$406K Hold
1,475
– – 0.09% 207
2013
Q3 		$461K Buy
+1,475
New +$388K 0.11% 192

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

CIBC Bank USA's REGN Position: Q4 2019 in Review

CIBC Bank USA increased its Regeneron Pharmaceuticals (REGN) stake by 3.5% in Q4 2019, buying an estimated $16.8K and bringing the position to 1,480 shares worth $556K. The position accounts for 0.07% of the portfolio, ranked #160.

CIBC Bank USA first reported a position in REGN in Q3 2013 and has held it in 13 quarters since. The position peaked at $824K in Q2 2015. 702 funds tracked by Wall St. Rank hold REGN as of Q4 2019.

  • CIBC Bank USA held 1,480 shares of Regeneron Pharmaceuticals worth $556K as of Q4 2019.
  • CIBC Bank USA bought 50 Regeneron Pharmaceuticals shares in Q4 2019, an estimated $16.8K.
  • Regeneron Pharmaceuticals made up 0.07% of CIBC Bank USA's portfolio in Q4 2019, its #160 holding.
  • CIBC Bank USA first reported a position in Regeneron Pharmaceuticals in Q3 2013 and has held it in 13 quarters since.
  • CIBC Bank USA's Regeneron Pharmaceuticals position peaked at $824K in Q2 2015.
  • 702 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2019.

Based on CIBC Bank USA's 13F filing for Q4 2019, filed 29 Jan 2020.